Board of Directors

Pharmaceutical and biotechnology products
Home » About Us » Leadership » Board of Directors » Kevin Hershberger

Kevin Hershberger, R.Ph., MBA,

President of Program Management at Great Lakes Drug Development, a division of Pharsight. Previously he held the position of Chief Operating Officer and Head of Program Management at Great Lakes Drug Development, and overseeing the sale of GLDD to Pharsight, a Certara company. Under his leadership, GLDD was named one of the “Michigan 50 Companies to Watch” in 2010.

He brings over 18 years of experience in the pharmaceutical industry primarily in project leadership roles to the Company. He is responsible for company operations and financial management. Mr. Hershberger’s experience includes Executive Director of Global Project Management at deCODE Genetics where he was responsible for leading the pharmaceutical portfolio development. Prior to joining deCODE Genetics, Mr. Hershberger held leadership roles of increasing responsibility within Parke-Davis, Pfizer and Takeda Pharmaceutical R&D, primarily in the area of Global Project Management.

He completed his undergraduate degree in Applied Mathematics and Pharmacy at Ferris State University and received his MBA, with concentration in finance, from Wayne State University.